Johnson & Johnson COVID-19 Vaccine Information

The CDC and the U.S. Food and Drug Administration (FDA) recommend that use of Johnson & Johnson’s COVID-19 Vaccine resume in the US, after a temporary pause.

Updated April 25, 2021

If you received the Johnson & Johnson COVID-19 vaccine – information you should know:

  • Fewer than one per million Johnson & Johnson vaccinations are now under investigation. If there is indeed a risk of blood clots from the vaccine, which has yet to be determined, that risk is extremely low.
    The risk of contracting COVID-19 in the United States is far higher.
  • Six recipients, all women aged 18-48 in the United States, developed the rare disorder within about two weeks of receiving the Johnson & Johnson COVID-19 vaccine.
  • Contact The Family Health Centers if you develop symptoms such as a severe headache, abdominal pain, leg pain or shortness of breath.
  • Patients should not be concerned about mild headaches and flu-like symptoms in the first few days after receiving the COVID-19 vaccine. These are common, harmless side effects brought on by the immune system’s production of a defense against the Coronavirus / COVID-19.
v-safe logo

Please sign up for the "v-safe after-vaccination check" after you receive the COVID-19 vaccine

V-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination.  Through v-safe, you can quickly tell the CDC if you have any side effects after receiving the COVID-19 vaccine.  Your personal information in v-safe is protected so that it stays confidential and private.

Use your smartphone to navigate your browser to vsafe.cdc.gov